SPY295.44+0.56 0.19%
DIA244.88-0.14 -0.06%
IXIC9,324.59+39.71 0.43%

BioXcel Therapeutics Q1 EPS $(0.790) Misses $(0.590) Estimate

BioXcel Therapeutics (NASDAQ:BTAI) reported quarterly losses of $(0.790) per share which missed the analyst consensus estimate of $(0.590) by 33.9 percent. This is a 71.74 percent decrease over losses of $(0.460) per

Benzinga · 05/12/2020 11:06

BioXcel Therapeutics (NASDAQ:BTAI) reported quarterly losses of $(0.790) per share which missed the analyst consensus estimate of $(0.590) by 33.9 percent. This is a 71.74 percent decrease over losses of $(0.460) per share from the same period last year.